← Eichor
Condition: Arrhythmogenic Right Ventricular Dysplasia Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Arrhythmogenic Right Ventricular Dysplasia

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Open-label, Dose Escalation Study of Safety and Preliminary Efficacy of TN-401 in Adults With PKP2 Mutation-associated A
Phase 1 · 7 location(s) · Tenaya Therapeutics · NCT06228924Mayo AVC Registry and Biobank
Phase N/A · 2 location(s) · Mayo Clinic · NCT03049254Cardiomyopathies and Heart Muscle Diseases: Cardiac Imaging in the Evaluation of Myocardial Fibrosis Transition
Phase N/A · 1 location(s) · University of Edinburgh · NCT06409585A Study to Assess Real-world Patient Characteristics and Clinical Course for Symptomatic Patients With PKP2-ACM
Phase N/A · 6 location(s) · Lexeo Therapeutics · NCT06976606Local Inflammation in Arrhythmogenic Right Ventricular Cardiomyopathy
NA · 1 location(s) · University Hospital, Toulouse · NCT05209776Non-interventional Study of Seroprevalence of Pre-existing Antibodies Against Adenovirus-associated Virus Vector (AAV9)
Phase N/A · 21 location(s) · Tenaya Therapeutics · NCT06311708Clinical Cohort Study - TRUST
Phase N/A · 1 location(s) · Universitätsklinikum Hamburg-Eppendorf · NCT05521451Arrhythmogenic Activity During Exercise in ARVC Patients
NA · 1 location(s) · Swiss Federal Institute of Technology · NCT06040242FAPI PET/CT Imaging in Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC) (FAPI-ARVC))
NA · 1 location(s) · Istanbul University - Cerrahpasa · NCT07563660Blockade of the Renin-angiotensin-aldosterone System in Patients With ARVD
Phase 2 · 13 location(s) · Hospices Civils de Lyon · NCT03593317Multimodal and Multidisciplinary Approach to Optimize Diagnostic, Prognostic, and Therapeutic Management of Patients wit
Phase N/A · 1 location(s) · Scientific Institute San Raffaele · NCT06607471Pediatric Cardiomyopathy Mutation Analysis
Phase N/A · 1 location(s) · Indiana University · NCT02432092Targeted Therapy With Glycogen Synthase Kinase-3 Inhibition for Arrhythmogenic Cardiomyopathy
Phase 2 · 17 location(s) · Hamilton Health Sciences Corporation · NCT06174220China Structural Ventricular Arrhythmias Registry
Phase N/A · 1 location(s) · China National Center for Cardiovascular Diseases · NCT03821051DZHK TORCH-Plus is a Registry for Patients With Cardiomyopathies and Serves as Source for Cardiovascular Research Studie
Phase N/A · 1 location(s) · University Hospital Heidelberg · NCT04265040Cardiovascular Multimodality Imaging Study
Phase N/A · 1 location(s) · Montefiore Medical Center · NCT06610019National Network for Cardiovascular Genomics: Advancing Cardiovascular Healthcare for Hereditary Diseases in Brazil's Un
Phase N/A · 27 location(s) · Hospital do Coracao · NCT06546137Distribution of Cell-cell Junction Proteins in Arrhythmic Disorders
Phase N/A · 1 location(s) · St. George's Hospital, London · NCT04257994PKP2-ACM Natural History Study
Phase N/A · 3 location(s) · Rocket Pharmaceuticals Inc. · NCT06644742A Phase 1, Dose Escalation Trial of RP-A601 in Subjects With PKP2 Variant-Mediated Arrhythmogenic Cardiomyopathy (PKP2-A
Phase 1 · 3 location(s) · Rocket Pharmaceuticals Inc. · NCT05885412
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.